79 related articles for article (PubMed ID: 25025285)
1. A high-affinity peptide for nicotinic acetylcholine receptor-α1 and its potential use in pulmonary drug delivery.
Park S; Kim YJ; Jon S
J Control Release; 2014 Oct; 192():141-7. PubMed ID: 25025285
[TBL] [Abstract][Full Text] [Related]
2. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
3. Nicotine binding to native and substituted peptides comprising residues 188-207 of nicotinic acetylcholine receptor alpha1, alpha2, alpha3, alpha4, alpha5, and alpha7 subunits.
Lentz TL
Biochem Biophys Res Commun; 2000 Feb; 268(2):480-4. PubMed ID: 10679230
[TBL] [Abstract][Full Text] [Related]
4. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
Chiara DC; Xie Y; Cohen JB
Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
[TBL] [Abstract][Full Text] [Related]
5. Enhanced pulmonary absorption of a macromolecule through coupling to a sequence-specific phage display-derived peptide.
Morris CJ; Smith MW; Griffiths PC; McKeown NB; Gumbleton M
J Control Release; 2011 Apr; 151(1):83-94. PubMed ID: 21182881
[TBL] [Abstract][Full Text] [Related]
6. Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors.
López-Vera E; Aguilar MB; Schiavon E; Marinzi C; Ortiz E; Restano Cassulini R; Batista CV; Possani LD; Heimer de la Cotera EP; Peri F; Becerril B; Wanke E
FEBS J; 2007 Aug; 274(15):3972-85. PubMed ID: 17635581
[TBL] [Abstract][Full Text] [Related]
7. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.
Marinou M; Tzartos SJ
Biochem J; 2003 Jun; 372(Pt 2):543-54. PubMed ID: 12614199
[TBL] [Abstract][Full Text] [Related]
8. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
[TBL] [Abstract][Full Text] [Related]
9. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.
Zang L; Shi L; Guo J; Pan Q; Wu W; Pan X; Wang J
Cancer Lett; 2009 Aug; 281(1):64-70. PubMed ID: 19327883
[TBL] [Abstract][Full Text] [Related]
10. Novel Strategy Utilizing Extracellular Cysteine-Rich Domain of Membrane Receptor for Constructing d-Peptide Mediated Targeted Drug Delivery Systems: A Case Study on Fn14.
Li Z; Xie J; Peng S; Liu S; Wang Y; Lu W; Shen J; Li C
Bioconjug Chem; 2017 Aug; 28(8):2167-2179. PubMed ID: 28715634
[TBL] [Abstract][Full Text] [Related]
11. Molecular interactions of the physiological anti-hypertensive peptide catestatin with the neuronal nicotinic acetylcholine receptor.
Sahu BS; Mohan J; Sahu G; Singh PK; Sonawane PJ; Sasi BK; Allu PK; Maji SK; Bera AK; Senapati S; Mahapatra NR
J Cell Sci; 2012 May; 125(Pt 9):2323-37. PubMed ID: 22357947
[TBL] [Abstract][Full Text] [Related]
12. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.
Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH
J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857
[TBL] [Abstract][Full Text] [Related]
13. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
14. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
Tsetlin V; Utkin Y; Kasheverov I
Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
[TBL] [Abstract][Full Text] [Related]
15. The role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptors.
Purohit PG; Tate RJ; Pow E; Hill D; Connolly JG
Br J Pharmacol; 2007 Apr; 150(7):920-31. PubMed ID: 17293883
[TBL] [Abstract][Full Text] [Related]
16. Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line.
Lukas RJ
J Pharmacol Exp Ther; 1993 Apr; 265(1):294-302. PubMed ID: 8474012
[TBL] [Abstract][Full Text] [Related]
17. AlphaC-conotoxin PrXA: a new family of nicotinic acetylcholine receptor antagonists.
Jimenez EC; Olivera BM; Teichert RW
Biochemistry; 2007 Jul; 46(30):8717-24. PubMed ID: 17608455
[TBL] [Abstract][Full Text] [Related]
18. Nonidentity of the alpha-neurotoxin binding sites on the nicotinic acetylcholine receptor revealed by modification in alpha-neurotoxin and receptor structures.
Ackermann EJ; Taylor P
Biochemistry; 1997 Oct; 36(42):12836-44. PubMed ID: 9335541
[TBL] [Abstract][Full Text] [Related]
19. Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display.
Writer MJ; Marshall B; Pilkington-Miksa MA; Barker SE; Jacobsen M; Kritz A; Bell PC; Lester DH; Tabor AB; Hailes HC; Klein N; Hart SL
J Drug Target; 2004 May; 12(4):185-93. PubMed ID: 15506167
[TBL] [Abstract][Full Text] [Related]
20. Biomedical Applications of a Novel Class of High-Affinity Peptides.
Saw PE; Xu X; Kim S; Jon S
Acc Chem Res; 2021 Sep; 54(18):3576-3592. PubMed ID: 34406761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
